
Lilly is enduring one of the bleakest financial years in its history as patent expiries continue to take chunks out …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

